USPTO serial 90856331
WILK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 23, 2024
- Examiner
- DUBIN, DAVID I
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with WILK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz VENABLE LLPP.O. BOX 34385WASHINGTON, DC 20043UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biotechnological preparations for use in industry, namely, chemicals for use in biotechnological manufacturing processes being biotechnological preparations containing cell-based cultured milk for use in the cosmetics industry; biotechnological preparations for use in industry, namely, chemicals for use in biotechnological manufacturing processes being biotechnological preparations containing cell-based cultured milk for use in the food industry; carbohydrates used as an ingredient in the manufacture of nutraceuticals; oligosaccharides as raw materials being human milk oligosaccharides, namely, chemical additives for use in the manufacture of foods; milk ferments for the food industry; proteins for use in the manufacture of food and beverages; proteins used in the manufacture of food supplements; proteins for use in the manufacture of cosmetics; cell-based cultured milk lipids for use in manufacture of food products and beverages; cell-based cultured milk lipids for use in manufacture of food supplements; cell-based cultured milk lipids for use in manufacture of cosmetics | ACTIVE | — |
| 003 | Cosmetic products which contain cell-based cultured milk components, namely, cosmetic creams, hair dyes and Basma dyes for cosmetic purposes, lotions for cosmetic purposes, gels for cosmetic purposes, cosmetic masks, cosmetic pads, cosmetic soaps, hair care preparations; cosmetic preparations for skin care; make-up | ACTIVE | — |
| 005 | Nutraceuticals for medical purposes for the treatment of illness and medical conditions in high risk pre-term newborns, and gut and intestine colitis for patients; nutraceuticals for use as a dietary supplement; biotechnological preparations containing cell-based cultured milk for medical purposes, namely, milk ferments for pharmaceutical purposes and probiotic milk ferments in the nature of milk ferments for pharmaceutical purposes; milk ferments for pharmaceutical purposes; food for babies and infants; cell-based cultured milk formula for babies, namely, cell cultured human breast milk; oligosaccharides, namely, human milk oligosaccharides being food for infants in the nature of human breast milk | ACTIVE | — |
| 029 | Cell-based cultured milk; cell-based cultured milk products excluding ice cream, namely, cultured milk; cell-based cultured cow's milk and cow's milk products excluding ice cream, namely, cultured milk; cell-based cultured sheep milk and sheep milk products excluding ice cream, namely, cultured milk; cell-based cultured goat milk and goat milk products excluding ice cream, namely, cultured milk; cell-based cultured camel milk and camel milk products excluding ice cream, namely, cultured milk; cell-based cultured buffalo milk and buffalo milk products excluding ice cream, namely, cultured milk | ACTIVE | — |
| 042 | Research and development services in the field of biotechnology; biotechnological research and development relating to cell-based cultured milk; biotechnological research and development relating to cell-based cultured milk for the medical industry; biotechnological research and development relating to cell-based cultured milk for the food industry; biotechnological research and development relating to cell-based cultured milk for the cosmetics industry; product development for others in the field of biotechnology; biotechnological product development in the field of cell-based cultured milk | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biomilk Ltd.
- Other trademarks owned by Biomilk Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 042
- Similar marks named WILK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 23, 2024 | NRCS | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 23, 2024 | NRCS | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 23, 2024 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Oct 1, 2023 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Sep 8, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 8, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 8, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 8, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 9, 2023 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jun 9, 2023 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Jun 9, 2023 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Jun 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 6, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 6, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 9, 2023 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 9, 2023 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 9, 2023 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 9, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 9, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 9, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 9, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 6, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 6, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Dec 6, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 6, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 6, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 24, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 24, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 21, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 29, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 29, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2021 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Oct 4, 2021 | ALIE | ASSIGNED TO LIE | — |
| Sep 27, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 3, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 2, 2021 | NWAP | NEW APPLICATION ENTERED | — |